Literature DB >> 9890643

Ascorbate 6-palmitate protects human erythrocytes from oxidative damage.

D Ross1, S Mendiratta, Z C Qu, C E Cobb, J M May.   

Abstract

Lipid-soluble antioxidants, such as alpha-tocopherol, protect cell membranes from oxidant damage. In this work we sought to determine whether the amphipathic derivative of ascorbate, ascorbate 6-palmitate, is retained in the cell membrane of intact erythrocytes, and whether it helps to protect the cells against peroxidative damage. We found that ascorbate 6-palmitate binding to erythrocytes was dose-dependent, and that the derivative was retained during the multiple wash steps required for preparation of ghost membranes. Ascorbate 6-palmitate remained on the extracellular surface of the cells, because it was susceptible to oxidation or removal by several cell-impermeant agents. When bound to the surface of erythrocytes, ascorbate 6-palmitate reduced ferricyanide, an effect that was associated with generation of an ascorbyl free radical signal on EPR spectroscopy. Erythrocyte-bound ascorbate 6-palmitate protected membrane alpha-tocopherol from oxidation by both ferricyanide and a water-soluble free radical initiator, suggesting that the derivative either reacted directly with the exogenously added oxidant, or that it was able to recycle the alpha-tocopheroxyl radical to alpha-tocopherol in the cell membrane. Ascorbate 6-palmitate also partially protected cis-parinaric acid from oxidation when this fluorescent fatty acid was intercalated into the membrane of intact cells. These results show that an amphipathic ascorbate derivative is retained on the exterior cell surface of human erythrocytes, where it helps to protect the membrane from oxidant damage originating outside the cells.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9890643     DOI: 10.1016/s0891-5849(98)00198-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  6 in total

Review 1.  The SLC23 family of ascorbate transporters: ensuring that you get and keep your daily dose of vitamin C.

Authors:  James M May
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

Review 2.  Treatment strategies for glucose-6-phosphate dehydrogenase deficiency: past and future perspectives.

Authors:  Adriana A Garcia; Ana Koperniku; Julio C B Ferreira; Daria Mochly-Rosen
Journal:  Trends Pharmacol Sci       Date:  2021-08-10       Impact factor: 17.638

3.  The lipophilic vitamin C derivative, 6-o-palmitoylascorbate, protects human lymphocytes, preferentially over ascorbate, against X-ray-induced DNA damage, lipid peroxidation, and protein carbonylation.

Authors:  Li Xiao; Takeki Tsutsui; Nobuhiko Miwa
Journal:  Mol Cell Biochem       Date:  2014-06-05       Impact factor: 3.396

4.  Repurposed drugs and nutraceuticals targeting envelope protein: A possible therapeutic strategy against COVID-19.

Authors:  Gourab Das; Troyee Das; Nilkanta Chowdhury; Durbadal Chatterjee; Angshuman Bagchi; Zhumur Ghosh
Journal:  Genomics       Date:  2020-11-13       Impact factor: 5.736

Review 5.  Antioxidants in Alzheimer's Disease: Current Therapeutic Significance and Future Prospects.

Authors:  Pingal Pritam; Rahul Deka; Anuradha Bhardwaj; Rashi Srivastava; Dhruv Kumar; Abhimanyu Kumar Jha; Niraj Kumar Jha; Chiara Villa; Saurabh Kumar Jha
Journal:  Biology (Basel)       Date:  2022-01-28

Review 6.  Role of antioxidants and a nutrient rich diet in Alzheimer's disease.

Authors:  Gerald Veurink; George Perry; Sandeep Kumar Singh
Journal:  Open Biol       Date:  2020-06-17       Impact factor: 6.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.